Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending December 27, 2015
The Pathogenesis of Lacunar Stroke, Assessing associations in subtypes
Predicting Progression from MCI to AD, Markers in plasma and CSF hold predictive value
Surgical Exposure and Dementia, Is it a risk factor?
Radiosurgery in Cerebral Arteriovenous Malformations, Assessing durable benefits
Depression in MS Patients, Evaluating prevalence of therapy
Must reads for theWeek ending December 20, 2015
Axonal Loss in Optic Neuritis, Studying damage to the RNFL and GCC
Comorbidities in Myasthenia Gravis, Identifying the most common associations
Rituximab Therapy in MS and NMO, Assessing safety and efficacy over 50 patient years
AQP4 Antibodies in Lupus, Assessing their effect on neuromyelitis optica spectrum disorders
Fingolimod in Multiple Sclerosis, Evaluating changes in lymphocyte subset distribution
Must reads for theWeek ending December 13, 2015
Fingolimod as Second-line Therapy in RRMS, Comparing it with a second iDMT
MOG and AQP4 Antibodies in Neuromyelitis Optica, Studying their associations in children
Fingolimod in Relapsing Multiple Sclerosis, Comparing it with placebo
Genetic Factors in Multiple Sclerosis, How do they affect IFNβ response?
Disease-Modifying Drugs in RRMS, Associations with disability progression
Must reads for theWeek ending December 6, 2015
MRI Lesion Detection in Multiple Sclerosis, Comparing conventional and “advanced” techniques
IL-17A in Myasthenia Gravis, Studying associations with sex and disease severity
14bp Polymorphism in Multiple Sclerosis, Could it be a risk factor?
B Cells in Relapsing-Remitting Multiple Sclerosis, Revealing their coordination capabilities
Interferon Beta Stimulated Genes in Multiple Sclerosis, Could they be early biomarkers of treatment response?
Must reads for theWeek ending November 29, 2015
Pregnancy After NMOSD Onset, Studying risk factors for miscarriage
Brain Aging Toward Dementia, Assessing decline over time
CAG Expansion in Huntington Disease, Measuring its effect on motor, cognitive, and behavioral scores
Intravenous Methylprednisolone in MS and NMO, Evaluating the effects of subsequent courses
Neuromyelitis Optica Diagnostic Criteria, Assessing their clinical utility